These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38735135)
1. Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells. Ma R; Hu K; Dai S; Wang Y Biochem Biophys Res Commun; 2024 Jul; 718():150037. PubMed ID: 38735135 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of YAP1-mediated trophoblast ferroptosis in recurrent pregnancy loss. Chen L; Dai F; Huang Y; Chen J; Li Z; Liu H; Cheng Y J Assist Reprod Genet; 2024 Jun; 41(6):1669-1685. PubMed ID: 38526774 [TBL] [Abstract][Full Text] [Related]
3. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11. Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004 [TBL] [Abstract][Full Text] [Related]
4. Radiation-induced YAP/TEAD4 binding confers non-small cell lung cancer radioresistance via promoting NRP1 transcription. Wang M; Yi J; Gao H; Wei X; Xu W; Zhao M; Zhao M; Shen Y; Wang Z; Wu N; Wei W; Jin S Cell Death Dis; 2024 Aug; 15(8):619. PubMed ID: 39187525 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1. Zhang MY; Lin J; Kui YC Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169 [TBL] [Abstract][Full Text] [Related]
6. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1. Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression. Li L; Liu D; Chen T; Wei C; Qiao Y; Liu W; Liang Y; Liang Z; Chen C; Li D; Wu B; Zhao X; Huang D; Wu D J Exp Clin Cancer Res; 2024 Jul; 43(1):200. PubMed ID: 39030638 [TBL] [Abstract][Full Text] [Related]
9. YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation. Osman I; Dong K; Kang X; Yu L; Xu F; Ahmed ASI; He X; Shen J; Hu G; Zhang W; Zhou J J Mol Cell Cardiol; 2021 Jul; 156():20-32. PubMed ID: 33753119 [TBL] [Abstract][Full Text] [Related]
10. CMTM5 influences Hippo/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination. Fan Y; Zou HQ Kaohsiung J Med Sci; 2024 Oct; 40(10):890-902. PubMed ID: 39166861 [TBL] [Abstract][Full Text] [Related]
11. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells. Li H; Lan H; Zhang M; Zhao F; An N; Yi C Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650 [TBL] [Abstract][Full Text] [Related]
12. YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH. Fu X; Wu H; Li C; Deng G; Chen C Mol Cell Biochem; 2024 Sep; 479(9):2415-2427. PubMed ID: 37773303 [TBL] [Abstract][Full Text] [Related]
13. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
14. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells. Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272 [TBL] [Abstract][Full Text] [Related]
15. HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway. Zheng S; Mo J; Zhang J; Chen Y Oncol Lett; 2023 Mar; 25(3):90. PubMed ID: 36817050 [TBL] [Abstract][Full Text] [Related]
16. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α. Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477 [TBL] [Abstract][Full Text] [Related]
17. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569 [TBL] [Abstract][Full Text] [Related]
18. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1). He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828 [TBL] [Abstract][Full Text] [Related]
19. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network. Qu R; Ma J Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737 [TBL] [Abstract][Full Text] [Related]
20. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells. Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]